February 2026 Monthly Dividend of $0.12 Per Share of Common StockRMBS Portfolio Characteristics as of January 31, 2026Next Dividend Announcement Expected March 18, 2026 VERO BEACH, Fla., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Orchid Island Capital, Inc. (the “Company”) (NYSE: ORC) announced today that the Board of Directors of the Company declared a monthly cash dividend for the month of February 2026. The dividend of $0.12 per share will be paid March 30, 2026 to holders of record of the Company’s common stock ...

Conference Call Scheduled for 9:00 a.m. ET on Thursday, February 19, 2026NEW YORK, Feb. 11, 2026 (GLOBE NEWSWIRE) -- Medallion Financial Corp. (NASDAQ: MFIN, the “Company”), a specialty finance company that originates and services loans in various consumer and commercial industries, as well as loan products and services offered through fintech strategic partners, announced today that it will report its financial results for the quarter and year ended December 31, 2025, after market close on Wednesday, Febru ...

Core Insights - Royalty Pharma experienced a "landmark year" in 2025, achieving double-digit growth in both portfolio and royalty receipts, and internalizing its external manager to enhance governance and reduce costs [2][5][18] Financial Performance - The company reported a return on invested capital (ROIC) of 15.8% and return on equity (ROE) of 22.8% for 2025 [5] - Royalty receipts grew by 13% for the year and 17% in the fourth quarter, while portfolio receipts increased by 16% for the year and 18% in the fourth quarter [13] - The company ended 2025 with $619 million in cash, $9.2 billion in debt, and a leverage ratio of approximately 3x [3][15] Cost Management - Management expects to achieve $100 million in cost savings in 2026 due to the internalization of the external manager, aiming for an operating and professional cost ratio of 4%–5% over time [1][5] Strategic Transactions - In 2025, Royalty Pharma executed eight transactions with a total announced value of $4.7 billion, deploying $2.6 billion, marking its strongest year for synthetic royalties [4][6][7] - The company reviewed over 480 potential royalty transactions, resulting in 109 in-depth reviews and 35 proposals [6] 2026 Guidance - For 2026, management guided portfolio receipts of $3.275 billion to $3.425 billion, implying a royalty growth of approximately 3% to 8% [3][16] - The guidance reflects anticipated headwinds from product loss of exclusivity and the introduction of biosimilars [2][16] Pipeline and Future Catalysts - The company estimates combined peak sales of over $43 billion across 20 development-stage therapies, translating to more than $2.1 billion in peak annual royalties [11] - Upcoming pivotal readouts are expected over the next 24 months, including data from Revolution Medicines and Novartis [17] Capital Allocation - Royalty Pharma returned $1.7 billion to shareholders in 2025 through $1.2 billion in buybacks and over $500 million in dividends [14]

PRA Group (NASDAQ:PRAA – Get Free Report) is expected to release its Q4 2025 results before the market opens on Wednesday, February 18th. Analysts expect PRA Group to post earnings of $0.50 per share for the quarter. Investors can check the company’s upcoming Q4 2025 earning summary page for the latest details on the call scheduled for Friday, February 20, 2026 at 4:00 PM ET. Get PRA Group alerts: PRA Group Trading Up 1.1%Shares of NASDAQ PRAA opened at $11.35 on Wednesday. The company has a 50 day simple ...

Financial Data and Key Metrics Changes - For the quarter ended December 31st, Core Net Investment Income was $0.27 per share, consistent with GAAP net investment income [5][14] - Net realized and unrealized change on investments resulted in a loss of $30 million, with NAV decreasing to $10.49 per share, down 3.1% from the previous quarter [14] - Debt-to-equity ratio was reported at 1.57x, which was reduced to 1.5x after selling assets post-quarter end [15] Business Line Data and Key Metrics Changes - The new joint venture, PSSL II, invested $197 million during the quarter and an additional $133 million after the quarter end, with a total portfolio currently at $326 million [5][6] - The portfolio remains well-diversified, comprising 160 companies across 50 industries, with a weighted average yield on debt investments at 9.9% [15][16] - PIK interest represented only 2.5% of total interest income, indicating a conservative portfolio structure [8][16] Market Data and Key Metrics Changes - The current market environment shows an increase in M&A transaction activity across the private middle market, expanding the pipeline of new investment opportunities [6][7] - Pricing on high-quality first lien term loans remains attractive, typically ranging from SOFR plus 475-525 basis points, with leverage around 4.5x EBITDA [7] Company Strategy and Development Direction - The company aims to scale PSSL II to over $1 billion in assets, consistent with existing joint ventures, focusing on generating a steady, stable dividend stream while preserving capital [6][13] - The strategy emphasizes strong private equity sponsor relationships and disciplined underwriting, which are seen as competitive advantages in the current lending environment [7][11] Management's Comments on Operating Environment and Future Outlook - Management expressed optimism about the M&A activity driving repayments of existing portfolio investments and the potential for equity rotation into new income-producing investments [6][24] - The company believes it is well-positioned to cover dividends as the new joint venture ramps up, although this will depend on M&A activity and market conditions [24][25] Other Important Information - The company has invested $8.7 billion in 545 companies, with a loss ratio on invested capital of only 13 basis points annually since inception [12] - The focus remains on core middle market companies, typically those with $10 million-$50 million of EBITDA, which operate below the threshold of high yield markets [11] Q&A Session Summary Question: Why is software such a low exposure within the portfolio? - Management indicated that the low exposure to software (4.4%) is a strategic decision to focus on cash flow loans with reasonable multiples and strong covenant protections, avoiding high-leverage, covenant-lite structures prevalent in the market [19][21] Question: Does the expectation to cover the dividend assume full optimization of the new joint venture? - Management confirmed that the expectation to cover the dividend is based on ramping the joint venture to about $1 billion in assets, with M&A activity being a key driver [22][24] Question: What are the drivers of the unrealized marks in the quarter? - Management noted that most markdowns were related to the 2021 vintage, with some specific companies experiencing softness, but they do not foresee significant additional markdowns in the near term [40][44] Question: What is the mix of loans by vintage year in the portfolio? - Management did not have the exact data on hand but suggested that it would be useful for further analysis [45] Question: Is there a lot of activity around the software sector in M&A? - Management indicated that they are not major players in the software lending space and suggested that M&A activity in the sector may be lower as the market stabilizes [49][51]

Core Viewpoint - Standard Premium Finance Holdings, Inc. is poised for growth and expansion, as evidenced by its participation in the upcoming National Investment Banking Association conference, where it will present its achievements and industry insights [1][2]. Company Overview - Standard Premium Finance Holdings, Inc. has financed over $2 billion in property and casualty insurance policies since its inception in 1991 and currently operates in 42 states [4]. - The company is actively seeking mergers and acquisitions to leverage economies of scale [4]. Growth Strategy - The company is expanding its national presence through state licensing approvals, now licensed in 42 states [2]. - Standard Premium is scaling its business by expanding its $115 million credit facility and building out its acquisition pipeline [2]. - The company has experienced rapid portfolio growth and increased loan originations, contributing to year-over-year revenue gains [2]. Conference Participation - Brian Krogol, CFO, will present at the NIBA conference on March 12, 2026, sharing data that supports the company's growth trajectory and industry overview [1]. - William Koppelmann, CEO, emphasizes the conference as an opportunity to engage with industry peers and articulate growth opportunities [2]. - One-on-one meetings with investors will be available throughout the conference [3].

Financial Data and Key Metrics Changes - For the quarter ended December 31, Core Net Investment Income was $0.27 per share, consistent with GAAP net investment income [5][14] - NAV decreased by 3.1% from $10.83 per share to $10.49 per share [14] - Debt-to-equity ratio was 1.57 times, reduced to 1.5 times after asset sales post-quarter end [15] Business Line Data and Key Metrics Changes - The new joint venture, PSSL Two, invested $197 million during the quarter, with a total portfolio of $326 million [5][6] - The portfolio remains well-diversified, comprising 160 companies across 50 industries, with a weighted average yield on debt investments of 9.9% [15][16] - PIK interest represented only 2.5% of total interest income, indicating a conservative portfolio structure [8][16] Market Data and Key Metrics Changes - An increase in M&A transaction activity in the private Middle Market is noted, expanding the pipeline of new investment opportunities [6][7] - Pricing on high-quality first lien term loans remains attractive, typically ranging from SOFR plus 475-525 basis points [7] Company Strategy and Development Direction - The company aims to scale PSSL Two to over $1 billion in assets, consistent with existing joint ventures [6] - The focus remains on core Middle Market companies, providing strategic capital with strong underwriting and covenant protections [11][12] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in covering dividends through projected run rate NII from the new joint venture, contingent on M&A activity [24][25] - The current environment is seen as favorable for lenders with strong private equity sponsor relationships [7] Other Important Information - The company has invested $8.7 billion in 545 companies, with a loss ratio on invested capital of only 13 basis points annually [12] - The company continues to originate attractive investment opportunities, investing $301 million at a weighted average yield of 10% during the quarter [12][13] Q&A Session Summary Question: Why is software such a low exposure within the portfolio? - Management indicated that the low exposure is a strategic decision to focus on cash flow loans with reasonable multiples and strong covenants, avoiding high-leverage software loans [19][21] Question: Does the expectation to cover the dividend assume full optimization of the new JV? - Management confirmed that the expectation is based on ramping the JV to about $1 billion, with M&A activity expected to populate the JV and facilitate equity rotation [22][24] Question: What are the drivers of the unrealized marks in the quarter? - Management noted that markdowns were primarily related to the 2021 vintage, with some specific companies experiencing softness, but overall, they do not foresee significant additional markdowns [41][44] Question: What is the mix of loans by vintage year in the portfolio? - Management did not have the exact data on hand but suggested that it would be useful for further analysis [45] Question: Is the $3.6 million charge related to the credit amendment a recurring item? - Management clarified that the charge was about $500,000 and is a one-time item [48]

MENLO PARK, Calif., Feb. 10, 2026 (GLOBE NEWSWIRE) -- Runway Growth Finance Corp. (“Runway Growth” or the “Company”) (Nasdaq: RWAY), a leading provider of flexible capital solutions to late- and growth-stage companies seeking an alternative to raising equity, today announced that it will release its fourth quarter and full year 2025 financial results after market close on Thursday, March 12, 2026. Runway Growth will discuss its financial results on a conference call that day at 2:00 p.m. PT (5:00 p.m. ET). ...

SAN MATEO, Calif.--(BUSINESS WIRE)--Hercules Capital, Inc. (NYSE: HTGC) ("Hercules,†"Hercules Capital,†or the "Company†), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a new supplemental cash distribution of $0.28 per share, to be distributed equally over four quarters be. ...

- Bitcoin treasury as of January 31, 2026 was 364.1 BTC valued at $29.1 million or $1.36 per share1 TAMPA, Fla., Feb. 05, 2026 (GLOBE NEWSWIRE) -- LM Funding America, Inc. (NASDAQ: LMFA) (“LM Funding” or the “Company”), a Bitcoin treasury and mining company, today announced its preliminary, unaudited Bitcoin mining and operational update for the month ended January 31, 2026. MetricDecember 2025January 2026- Bitcoin2 - Mined, net7.57.8<td style="border-top: solid black 1pt ; border-right: solid black 1pt ; ...